BIOStartr Blog


Subscribe to our weekly BIOStartr Newsletter

Get your weekly update on BIOStartr and the biotech scene

* indicates required




Today´s antiviral biotech!

Novel treatments for chronic viral infections!

ContraVir is developing targeted antiviral therapies with two drug candidates in clinical studies. FV-100, now in a pivotal Phase 3 trials, is a novel therapeutic drug candidate to treat herpes zoster, or shingles. ContraVir is also developing CMX157, a highly potent analog of the successful antiviral drug tenofovir DF (Viread®).

Read more about the opportunities of these drug candidates on


Cells meet big data!

Grow Cancer to Fight Cancer!

Xcell Biosciences is a San Francisco-based life sciences company that has developed an innovative research and diagnostics platform utilizing its technology for capturing and growing tumor cells and immune cells directly from patient blood.
The company is able to capture the comprehensive set of genetic information for each patient’s cancer and track changes to that dataset overtime!


Weekly BIOStartr Newsletter

Keep up with BIOStartr and the biotech and startup scene and sign up to our weekly newsletter!

Take a look at this week’s BIOStartr newsletter here and subscribe now to get your weekly update

In this Issue

  • Join the BIOStartr Committee! – To provide our biotechs the best support possible we are building the BIOStartr Committe consisting of biotech experts and professionals
  • New biotechs on BIOStartr –  BIOStartr welcomes IdroPlan and Meridda, two promising biotechs
  • What’s going on in the lab? – Brits will swab surfers‘ bottoms to understand antibiotic-resistant bacteria
  • Weekly biotech news –  BIOStartr provides you with the most important headlines regarding biotech and startups of this week

Crowd-based financing in the Life Sciences?

When it comes to finding investors in the Life Sciences, crowd-based financing is still raising quite a few eyebrows….
In the last few years, more and more biotech and medtech firms have launched crowd financing campaigns. In Europe, this seems especially true for France, Germany, UK, Spain, Switzerland and the Netherlands.

But to date, no report has analysed the relevance of these alternative financial instruments for the Life Sciences industry and the specific challenges connected to this sector.

We at BIOStartr already know the specific challenges of the Life Sciences sector!
This is why BIOStartr is a B2B solution which addresses professional investors only. BIOStartr is confident that with a business model like this the newest innovations can be brought to life faster!

Read more about the Crowd Financing Survey on


Today´s silver biotech

Silver Hydrogel Nanostructured Wound Dressing!

RMD Biotech LLC has developed a product which offers extended protection for critical control of infection in chronic wounds and minor injuries. It is a non-woven, fibrous gauze dressing with controlled silver release used for dressing wounds and other open injuries.

Silver is an antimicrobial agent and has a history in wound healing dating back at least 2,000 years, since ancient Greece and Rome!

Support this highly innovative biotech in winning a grant! Click here and vote!
Thank you.


Insect Farming System

Automatized Insect Farming System!

EntoFactory is a young startup located in Chile, South America, focused on the development of solutions for Insect Farming. Currently it is working on the automation of mealworm production for elaboration of processed insect-based food and an organic industrialization of the traditionally manual separation and harvesting of these beetle larvae.


Arabidopsis uses molecular decoy to trick pathogens!

Plant cells have developed a receptor incorporating a decoy intended to catch the invader in its own trap!
As in humans, interception of pathogens by the immune system is essential for plants, allowing them to ensure their survival, growth and productivity. Their defense responses rely entirely on genetic resistance conferred by a family of receptors expressed in individual cells.
Ralstonia solanacearum, a bacterium responsible for bacterial wilt of many plant species has developed a particularly effective invasion strategy. Arabidopsis thaliana, which is one of the „preys“ of the bacterium Ralstonia solanacearum, uses a defense mechanism just as radical as that deployed by the bacterium.

Read more about the mechanism at

1 Litre of Love – today´s lovely biotech

Structured water, the easy way. Water is Technology.

The 1LitreofLove Project: A water-healing contraption that heals the body on a cellular level, using the miracle frequency of 528 Hz. The cheapest way to heal any illness, no expensive potions, powders or tinctures, just a jug with healing words on it, coupled with a powerful magnet!


The billion-dollar biotech!

Moderna Therapeutics has big ambitions and a bankroll to match. How a fledgling startup became one of the most highly valued private drug firms ever…

This January alone, Moderna Therapeutics announced a record $500 million in financing from a handful of investors, pushing it over the $1-billion fund-raising mark and making it the most highly valued venture-backed private company in drug development today.
Investors are clearly attracted to Moderna’s technology, which aims to use chemically modified messenger RNA (mRNA) molecules to produce any protein that the body might need.

Read more

Today´s wise biotech

Change the way medicines are discovered and developed!

Atomwise uses Deep Learning Neural Networks to discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection!